Search for: "Boehringer-Ingelheim"
Results 141 - 160
of 443
Sorted by Relevance
|
Sort by Date
4 Nov 2015, 9:34 am
According to a recent news article from the Washington Post, a federal watch group reports the United States Food and Drug Administration (FDA) exercised “lax” judgment and made “questionable” decisions to be accommodating to the pharmaceutical maker Boehringer Ingelheim when reviewing its application for the anticlotting medication known as Pradaxa. [read post]
22 Aug 2014, 2:05 pm
Claims are being made that Boehringer Ingelheim, the drugmaker, was more concerned with marketing and making money than patient safety and failed to warn users of this known danger or methods to minimize the risk of internal bleeding. [read post]
8 Nov 2020, 9:17 pm
Sanjit Kumar Chakraborty: Intellectual Property Rights, Agricultural Biotechnology and Food Security: Issues and Challenges in India (Source: SSRN) New Job Postings on Patently-O: Dorsey & Whitney Boehringer Ingelheim Klarquist [read post]
9 Jun 2019, 9:07 pm
Narechania: State Immunity and the Patent Trial and Appeal Board (Source: SSRN) New Job Postings on Patently-O: Weaver Austin Villeneuve & Sampson LLP Stoel Rives LLP Caldwell Intellectual Property Law Daly, Crowley, Mofford & Durkee, LLP Morgan, Lewis & Bockius LLP Boehringer Ingelheim Blackbird Technologies Knobbe Martens [read post]
1 Mar 2013, 9:53 pm
As reported, Bristol-Myers Squibb, Roche and Boehringer-Ingelheim have plans to join the pool. [read post]
11 Nov 2019, 3:21 am
In re Boehringer Ingelheim Vetmedica, Inc., Serial No. 87072333 (November 6, 2019) [not precedential] (Opinion by Judge David Mermelstein).During examination, the USPTO must analyze the specimens of use to determine whether the purported mark would be perceived as a source indicator. [read post]
17 Nov 2014, 1:20 pm
The first such new blood thinner released was Pradaxa (dabigatran), a direct thrombin inhibitor by Boehringer Ingelheim. [read post]
27 Jun 2018, 1:16 am
The Court concluded that their actions therefore would not amount to repackaging as set out in Boehringer Ingelheim. [read post]
27 Jun 2018, 1:16 am
The Court concluded that their actions therefore would not amount to repackaging as set out in Boehringer Ingelheim. [read post]
15 Jan 2015, 3:07 pm
Readers of this blog might recall that one drug maker, Boehringer Ingelheim, hid the uncontrolled bleeding it knew was happening during its trials of Pradaxa, a blood thinner. [read post]
12 Nov 2019, 6:50 am
This is because BOEHRINGER INGELHEIM (“BI”) filed an appeal, which is pending before the Supreme Court. [read post]
20 Sep 2012, 12:15 pm
Boehringer Ingelheim’s blood-thinning drug Pradaxa (dabigatran etexilate) is a $1 billion industry unto itself. [read post]
7 May 2010, 1:07 pm
Boehringer Ingelheim International GMBH v. [read post]
29 Apr 2012, 9:30 pm
The estate of a woman who died after taking Pradaxa is seeking wrongful death damages from drug maker Boehringer Ingelheim. [read post]
28 Jan 2014, 11:53 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
5 Dec 2014, 6:03 pm
According to notifications made to the U.S Food and Drug Administration, Pradaxa has been blamed for excessive bleeding, linked to over 12,000 injuries and more than 1,000 deaths Plaintiffs accused Boehringer Ingelheim of misrepresenting Pradaxa as a better drug than the blood thinner Warfarin. [read post]
11 Jan 2018, 12:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
12 Apr 2017, 2:22 pm
One hopes that Boehringer Ingelheim Pharmaceuticals (Pradaxa) or Janssen Pharmaceuticals (Xarelto) or one of the other responsible drug companies have such a drug-safety study currently underway or planned to begin soon. [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
14 Mar 2012, 10:42 am
Boehringer Ingelheim Pharmaceuticals Inc., et al.; U.S. [read post]
